UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells

Cancer research (Chicago, Ill.), 2017-10, Vol.77 (19), p.5374-5383

2017

Volltextzugriff (PDF)

PD-L1 expression in triple-negative breast cancer

Cancer immunology research, 2014-04, Vol.2 (4), p.361-370

2014

Volltextzugriff (PDF)

Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study

Blood cancer journal (New York), 2021-03, Vol.11 (3), p.60-60, Article 60

2021

Volltextzugriff (PDF)

Two unique HLA-A0201 restricted peptides derived from cyclin E as immunotherapeutic targets in leukemia

Leukemia, 2020-06, Vol.34 (6), p.1626-1636

2020

Volltextzugriff (PDF)

CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia

Frontiers in oncology, 2022-01, Vol.11, p.800110-800110

2022

Volltextzugriff (PDF)

Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma

Clinical cancer research, 2018-07, Vol.24 (14), p.3386-3396

2018

Volltextzugriff (PDF)

A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2

Frontiers in immunology, 2019-01, Vol.9, p.3153-3153

2019

Volltextzugriff (PDF)

Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma

Clinical cancer research, 2018-05, Vol.24 (10), p.2304-2311

2018

Volltextzugriff (PDF)

Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target

Frontiers in immunology, 2018-01, Vol.8, p.1975

2018

Volltextzugriff (PDF)

PR1-specific T cells are associated with unmaintained cytogenetic remission of chronic myelogenous leukemia after interferon withdrawal

PloS one, 2010-07, Vol.5 (7), p.e11770-e11770

2010

Volltextzugriff (PDF)

Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens

Blood advances, 2018-08, Vol.2 (16), p.2052-2062

2018

Volltextzugriff (PDF)

Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data

PloS one, 2011-08, Vol.6 (8), p.e23217-e23217

2011

Volltextzugriff (PDF)

Targeting Immune Checkpoints in Hematologic Malignancies

Pharmacological reviews, 2016-10, Vol.68 (4), p.1014-1025

2016

Volltextzugriff (PDF)

Clinical and Immunologic Effects of Subcutaneously Administered Interleukin-12 and Interferon Alfa-2b: Phase I Trial of Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma

Journal of clinical oncology, 2004-07, Vol.22 (14), p.2891-2900

2004

Volltextzugriff (PDF)

Targeting cathepsin G in myeloid leukemia

Oncoimmunology, 2013-04, Vol.2 (4), p.e23442-e23442

Alatrash, Gheath

2013

Volltextzugriff (PDF)

Rhabdomyolysis after ingestion of Foxy, a hallucinogenic tryptamine derivative

Mayo Clinic proceedings, 2006-04, Vol.81 (4), p.550-551

2006

Volltextzugriff (PDF)

A Public Neoantigen Produced By the SF3B1 K700E Mutation Is a Bona Fide T Cell Target in AML/MDS

Blood, 2023-11, Vol.142 (Supplement 1), p.6816-6816

2023

Volltextzugriff (PDF)

Overexpression of CD200 Is a Stem Cell-Specific Mechanism of Immune Escape in AML

Blood, 2020-11, Vol.136 (Supplement 1), p.14-15

2020

Volltextzugriff (PDF)

Single-Cell Profiling of CD8 Landscape in Treatment Naïve and Relapsed/Refractory AML Patients Reveals Distinct Effector Cellular States Predictive of Outcomes

Blood, 2022-11, Vol.140 (Supplement 1), p.9144-9145

2022

Volltextzugriff (PDF)

Siremadlin Monotherapy and in Combination with Donor Lymphocyte Infusion for Patients with Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation Who Are in Complete Remission but at High Risk for Relapse

Blood, 2022-11, Vol.140 (Supplement 1), p.8944-8945

2022

Volltextzugriff (PDF)

Cancer immunotherapies, their safety and toxicity

Expert opinion on drug safety, 2013-09, Vol.12 (5), p.631-645

2013

Volltextzugriff (PDF)

PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies

Leukemia, 2017-03, Vol.31 (3), p.697-704

2017

Volltextzugriff (PDF)

CD47 Blockade Enhances Phagocytic Activity of the TCR-Mimic Antibody Hu8F4 Against HLA-A2+ AML

Blood, 2023-11, Vol.142 (Supplement 1), p.4176-4176

2023

Volltextzugriff (PDF)

1 – 25 von 222

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(211)

Publikationsform

Sprache

Englisch
(222)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(63)
Humans
(54)
Oncology
(33)
Hematology
(31)
Female
(29)
Immunology
(29)
Immunotherapy
(28)
Adult
(22)
Male
(20)
Middle Aged
(20)
Transplantation
(18)
Acute Myeloid Leukemia
(14)
Leukemia
(14)
T-Lymphocytes, Cytotoxic - Immunology
(14)
Aged
(11)
Animals
(11)
Antigens
(11)
Hla-A2 Antigen - Immunology
(11)
Leukemia, Myeloid, Acute - Therapy
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(104)
Cancer Research
(18)
Biology Of Blood And Marrow Transplantation
(16)
Clinical Cancer Research
(10)
Journal Of Clinical Oncology
(9)
Cancer Immunology Research
(5)
Cytotherapy
(5)
Leukemia
(5)
British Journal Of Haematology
(4)
Cancer Prevention Research
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells

PD-L1 expression in triple-negative breast cancer

Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia

Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study

Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation

Two unique HLA-A0201 restricted peptides derived from cyclin E as immunotherapeutic targets in leukemia

CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia

Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma

A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2

Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma

Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target

PR1-specific T cells are associated with unmaintained cytogenetic remission of chronic myelogenous leukemia after interferon withdrawal

Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens

Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data

Targeting Immune Checkpoints in Hematologic Malignancies

Clinical and Immunologic Effects of Subcutaneously Administered Interleukin-12 and Interferon Alfa-2b: Phase I Trial of Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma

Targeting cathepsin G in myeloid leukemia

Rhabdomyolysis after ingestion of Foxy, a hallucinogenic tryptamine derivative

A Public Neoantigen Produced By the SF3B1 K700E Mutation Is a Bona Fide T Cell Target in AML/MDS

Overexpression of CD200 Is a Stem Cell-Specific Mechanism of Immune Escape in AML

Single-Cell Profiling of CD8 Landscape in Treatment Naïve and Relapsed/Refractory AML Patients Reveals Distinct Effector Cellular States Predictive of Outcomes

Siremadlin Monotherapy and in Combination with Donor Lymphocyte Infusion for Patients with Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation Who Are in Complete Remission but at High Risk for Relapse

Cancer immunotherapies, their safety and toxicity

PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies

CD47 Blockade Enhances Phagocytic Activity of the TCR-Mimic Antibody Hu8F4 Against HLA-A2+ AML

Suchergebnisse filtern